BREAKING NEWS
Three NIH-funded Researchers Win 2009 Nobel Prize
Drs. Elizabeth H. Blackburn of the University of California, San Francisco; Carol W. Greider of Johns Hopkins University School of Medicine; and Jack W. Szostak of Harvard Medical School have won the Nobel Prize in Physiology or Medicine for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase. Telomeres limit the number of times a cell can divide and therefore play an important role in aging and cancer.
NEWS
The Cancer Genome Atlas Project to Map 20 Tumor Types
During a visit to the NIH campus last week, President Barack Obama announced that NIH will spend $275 million over the next 2 years to catalogue the genetic changes driving more than 20 types of cancer. Read more > >
Hormone Therapy for Prostate Cancer May Pose Heart Risks
Clinical trial is being planned to test lapatinib in selected patientsBreast Cancer Trial Suspends Recruitment
Accrual suspended while researchers study adverse eventsHigh-dose Daunorubicin Benefits Younger Adults with Leukemia
Higher dose improved rates of remission and overall survival compared with standard doseMany Survivors of Childhood Cancers Have Healthy Babies
Studies find no overall increased risk of pregnancy complications or birth defectsInvestigational Drug Effective Against Metastatic Melanoma in Early Phase Trial
PLX4032 is moving into phase II and III trials for this difficult-to-treat diseaseInvasiveness of Breast Cancer Cells Linked to Two Proteins
Discovery could help doctors identify women at risk of invasive or metastatic disease
COMMENTARY
Director's Update: Global Cancer Control: An Essential Duty
At NCI, we clearly recognize cancer as a global health crisis, and one for which the worldwide impact—both personal and economic—is rapidly expanding. A recent study reported that in the past 30 years the global burden of cancer, based on the incidence of new cancer cases and annual deaths, has doubled. Read more > >
| Subscribe Now! |
IN DEPTH
Experts Tackle the Challenge of Managing Ductal Carcinoma In Situ
This highly treatable condition, which can lead to breast cancer, poses dilemmas for patients and their caregivers
Adapting Capsule Endoscopy for Colorectal Cancer Screening
Technical barriers must be overcome before use in colorectal cancer screening
Featured Clinical Trial: Targeting HER2 in the Treatment of Ductal Carcinoma In Situ
Will trastuzumab help prevent DCIS from recurring or progressing to invasive breast cancer?
Spokes of Hope: Surviving Cancer and Riding On
Cyclists Combating Cancer visit patients and politicians on national bike tour
UPDATES
Cancer.gov Update
- Cancer.gov Highlights Breast Cancer Awareness Month
- Searchable Database for Cancer Control Publications Now Available
- New Statistical Software Aids Health Disparities Research
Notes
- NCI Recognizes Clinical Investigators with New Team Leadership Award
- Recovery Act Funds Made Available to Expand NCCCP
- UC Berkeley Cancer Researcher Wins 2009 MacArthur Fellowship
- Dr. Thomas Waldmann Awarded Service to America Medal
- NIH FARE 2010 Awards Announced
- President's Cancer Panel Explores Effects of Demographic Change on Cancer
- NCI to Host Forum Connecting SBIR Companies and Potential Investors
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
